SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,580,552 | -8.3% | 93,600 | 0.0% | 0.49% | -4.8% |
| Q2 2023 | $2,813,616 | -16.5% | 93,600 | +0.6% | 0.52% | -2.1% |
| Q1 2023 | $3,369,390 | -23.8% | 93,000 | -25.0% | 0.53% | -26.5% |
| Q4 2022 | $4,423,080 | +5.4% | 124,000 | 0.0% | 0.72% | -0.6% |
| Q3 2022 | $4,197,000 | +11.6% | 124,000 | -4.6% | 0.72% | +11.7% |
| Q2 2022 | $3,760,000 | +11.9% | 130,000 | +25.0% | 0.65% | -0.8% |
| Q1 2022 | $3,361,000 | +10.8% | 104,000 | 0.0% | 0.65% | -2.0% |
| Q4 2021 | $3,033,000 | +22.3% | 104,000 | +11.8% | 0.67% | +21.8% |
| Q3 2021 | $2,480,000 | -13.4% | 93,000 | 0.0% | 0.55% | -7.8% |
| Q2 2021 | $2,863,000 | -24.1% | 93,000 | -35.4% | 0.59% | -23.6% |
| Q1 2021 | $3,770,000 | +193.8% | 144,000 | +182.4% | 0.78% | +131.0% |
| Q4 2020 | $1,283,000 | +309.9% | 51,000 | +240.0% | 0.34% | +304.8% |
| Q3 2020 | $313,000 | -12.1% | 15,000 | 0.0% | 0.08% | -8.8% |
| Q2 2020 | $356,000 | +31.9% | 15,000 | 0.0% | 0.09% | +24.7% |
| Q1 2020 | $270,000 | -24.2% | 15,000 | 0.0% | 0.07% | -35.4% |
| Q4 2019 | $356,000 | -48.2% | 15,000 | -40.0% | 0.11% | -42.1% |
| Q3 2019 | $687,000 | -16.9% | 25,000 | 0.0% | 0.20% | -15.6% |
| Q2 2019 | $827,000 | -41.0% | 25,000 | -37.5% | 0.23% | -32.7% |
| Q1 2019 | $1,402,000 | -35.1% | 40,000 | -38.5% | 0.34% | -34.2% |
| Q4 2018 | $2,159,000 | -14.3% | 65,000 | +30.0% | 0.52% | -28.6% |
| Q3 2018 | $2,518,000 | -15.8% | 50,000 | 0.0% | 0.73% | -9.3% |
| Q2 2018 | $2,992,000 | +30.7% | 50,000 | 0.0% | 0.80% | +27.0% |
| Q1 2018 | $2,290,000 | – | 50,000 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |